GetTopicDetailResponse(id=2120e16682b, topicName=白塞氏病, introduction=白塞氏病, content=null, image=null, comments=4, allHits=1728, url=https://h5.medsci.cn/topic?id=71668, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=57490, tagList=[TagDto(tagId=57490, tagName=白塞氏病)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2118572, encodeId=053a21185e2c9, content=<a href='/topic/show?id=2120e16682b' target=_blank style='color:#2F92EE;'>#白塞氏病#</a>(BD)是一種由細胞毒性T細胞和中性粒細胞介導的全身性血管炎。<a href='/topic/show?id=14109e840d4' target=_blank style='color:#2F92EE;'>#阿普斯特#</a>(<a href='/topic/show?id=46bc26903b' target=_blank style='color:#2F92EE;'>#Apremilast#</a>)是一種選擇性抑制<a href='/topic/show?id=0092e38496e' target=_blank style='color:#2F92EE;'>#磷酸二酯酶4#</a>(PDE4)的口服小分子藥物，最近已被批準用于治療BD, objectTitle=A&R：磷酸二酯酶4(PDE4)阻斷降低白塞病中性粒細胞的激活, objectType=article, longId=762155, objectId=33b8e62155d5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230309/1678295523215_5610093.png, objectUrl=/article/show_article.do?id=33b8e62155d5, replyNumber=0, likeNumber=200, createdTime=2023-03-10, rootId=0, userName=showtest, userId=8f0715, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=33b8e62155d5, moduleTitle=A&R：磷酸二酯酶4(PDE4)阻斷降低白塞病中性粒細胞的激活, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=33b8e62155d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1249009, encodeId=409b124900921, content=<a href='/topic/show?id=b6ade07681f' target=_blank style='color:#2F92EE;'>#病例#</a><a href='/topic/show?id=2120e16682b' target=_blank style='color:#2F92EE;'>#白塞氏病#</a>實在太好了！, objectTitle=NEJM：一名 32 歲男子，精神錯亂、頭痛和發(fā)燒, objectType=article, longId=739347, objectId=80a7e39347cc, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220901/3cd81f3451a74f7783a903be448afa47.jpg, objectUrl=/article/show_article.do?id=80a7e39347cc, replyNumber=0, likeNumber=169, createdTime=2022-09-15, rootId=0, userName=小小醫(yī)者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80a7e39347cc, moduleTitle=NEJM：一名 32 歲男子，精神錯亂、頭痛和發(fā)燒, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=80a7e39347cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1214609, encodeId=5ab11214609a2, content=<a href='/topic/show?id=d945e1670d9' target=_blank style='color:#2F92EE;'>#白塞病#</a><a href='/topic/show?id=2120e16682b' target=_blank style='color:#2F92EE;'>#白塞氏病#</a>, objectTitle=ACR 2021 ：白塞病的妊娠結(jié)局的薈萃分析, objectType=article, longId=220475, objectId=fd742204e546, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20211116/1637040226882_5552845.png, objectUrl=/article/show_article.do?id=fd742204e546, replyNumber=0, likeNumber=141, createdTime=2022-04-26, rootId=0, userName=病毒獵手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd742204e546, moduleTitle=ACR 2021 ：白塞病的妊娠結(jié)局的薈萃分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=fd742204e546)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1196037, encodeId=d388119603e58, content=<a href='/topic/show?id=2120e16682b' target=_blank style='color:#2F92EE;'>#白塞氏病#</a>二極管激光是治療白塞氏病相關(guān)口腔潰瘍的高效安全治療方式。二極管激光在控制疼痛和減少口腔潰瘍活動方面比曲安奈德更有效。, objectTitle=白塞氏病, objectType=topic, longId=71668, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=106, createdTime=2022-02-22, rootId=0, userName=yangchou, userId=88b489038, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
